The distribution of the Taq I polymorphism in the vitamin D receptor (VDR) gene and the MSc 1 polymorphism in the collagen 1 alpha 1 (COL 1AI) gene were studied in 266 female and 55 male patients attending an osteoporosis clinic. Allele frequency in control (T-or Z-score >-1.O) and osteoporotic (T-or Z-scores <-2.5) groups were compared using Chi squared tests. No differences were found between the 2 groups with either of the polymorphisms. When allele frequency was compared in patients with and without history of fracture, no differences were found in the frequency of the COLlAl alleles. However there were significantly more fracture patients, who had been previously treated with corticosteroids for other conditions, carrying the T allele of the VDR polymorphism (X 2 = 5.65, p>O.01<0.02). In conclusion, neither of these polymorphisms aid in the prediction of osteoporosis but the VDR T allele may carry an increased fracture risk in patients who require corticosteroid treatment.
INTRODUCTION
Bone mineral density (BMD) is regulated by a complex interaction of genetic and environmental factors. Polymorphisms in the vitamin D receptor (VDR) and regulatory region ofthe type I collagen gene (COLIAI) have been associated with decreased bone mass and increased risk of osteoporotic fractures. Morrison ' described a Taq I polymorphism in codon 352 of exon 9 of the VDR gene resulting from a C-+T transition. Grant2 described a novel G--T polymorphism in the regulatory region of the COLlAl gene which was found to be strongly associated with low BMD and increased risk of osteoporotic fracture. We have studied the distribution of these two polymorphisms in a group of people referred to the osteoporosis clinic in Northern Ireland to assess if there is any association between either of these genotypes and low bone mineral density (BMD) or the risk of osteoporotic fracture in our local population.
METHODS

Patients
Patients attending the osteoporosis clinic for bone scans were studied. These patients had been referred to the clinic for a variety of different reasons e.g. family history, early menopause and long term treatment with corticosteroids. The bone density was measured by dual energy X-ray absorptiometry (DXA) using a Hologic4500A bone densitometer. Lumbar spine (Ll-L4) and total hip BMD were measured and T-scores and Z-scores obtained. The local ethical committee approved the study and patients gave informed written consent. Blood was collected from 266 females (aged 28-83, median 64 years) and 55 males (aged 22-75, median 51 years). All subjects were Caucasian and 62 of the females (23%) and 10 of the males (18%) had a family history of osteoporosis. The BMD result from the subject's first visit was recorded and a blood sample sent for gene studies. At the end of the study (after the Receptor polymorphisms in osteoporosis genotyping had been carried out) the patients were classified as to whether or not they had been treated with corticosteroids, for other medical conditions, and whether or not they had suffered a low trauma fracture. Steroid treatment was defined as .7.5mg for .6months and the classification of a low trauma fracture was a subjective assessment made by the doctor after discussion with the patient.
DNA Isolation
Ten millilitres of blood was collected from each patient into tubes containing EDTA. The plasma was removed and the DNA was extracted from the white cells using the method of Jean Pierre. 3 The DNA was dissolved in Tris-EDTA buffer (1OmM) to give a concentration of approximately 250gg/mL and stored at -70°C until analysis.
Before analysis the samples were diluted to 25 [tg/ mL with double distilled, sterile water.
COLIAJ Genotyping
The primers used were those described by Grant The primers used were those described by Morrison ' namely a forward primer of 5'-CAGAGCATGGACAGGGAGCAA-3' and a reverse primer of 5'-GCAACTCCTCATGGCTGAGGTCTC-3'. The primers were purchased from Gibco BRL, Life Technologies, UK. PCR was carried out using Taq DNA polymerase (Gibco BRL) using standard conditions on a Perkin Elmer 2400 Thermal Cycler. The protocol was 35 cycles of 94°C for 30 seconds, 63°C for 20 seconds and 72°C for 20 seconds with an initial denaturing step of 94°C for 3 minutes and a final extension step of 72°C for 7 minutes. The PCR product was digested with Taqi for 2 hours at 65°C, the digests electrophoresed on a 2% agarose gel and stained with ethidium bromide. Homozygotes for the T nucleotide (TT) have two bands at 495bp and 245bp, heterozygotes with C-4T (Tt) have four bands at 495bp, 245bp, 290bp and 205bp and homozygotes for the C (tt) nucleotide have three bands at 290bp, 245bp and 205bp.
Statistics
The WHO criteria for defining patients with ostoeporosis classifies those with T-score of >-1.0 as "normal", <-1.0->-2.5 as osteopenic and < -2.5 as osteoporotic. The T-score compares the BMD with that of the mean for a young adult population. Since our population spanned such a (Tables II and III) . Those with T or Z scores >-1.0 were regarded as having normal bone density and were classified as our "Control" group. The normal (or control), osteopenic and osteoporotic groups were sorted according to whether or not they had received steroid therapy and whether or not they had sustained a low trauma fracture. The Chi-squared test was used to compare the frequency of the S with s and T with t alleles in patients who were classified as "controls" (T-or Z-score >-1.0) with those who were classified as "osteoporotic" (T-or Z-score <-2.5) using both the lumbar and hip BMO scans. Chi-squared was also used to compare the frequency of the S, s, T and t alleles in patients who had sustained a low trauma fracture with those who had no history of fracture.
Results
Fifty females and 22 males had received steroid therapy (.7.5mg for .6 months minimum).
Thirteen females and seven males were uncertain as to whether or not they had received a significant course of steroids. These 20 patients were included in the calculation of the overall genotype frequency in the population (Table I) association between COL 1 A l genotype and either BMD or fracture. Beaven12 has reported ethnic differences in the prevalence of the s allele, being lower in an African and Asian population than in European countries and Han et all3 have found the Spl polymorphism to be absent in a Korean population. However, all the studies mentioned above which found a positive association between the polymorphism and BMD or fracture risk were carried out with Caucasian European or American subjects, so racial differences are unlikely to be the reason for the disparity in the findings. In most cases the distribution of the genotypes was similar to ours in the non-osteoporotic population; it was in the osteoporotic group that the distribution ofthe genotypes differed in the studies which had positive findings. The criteria used to choose the patient group may be the key to the differences in the findings of the various studies. Utterlinden'4 whose overall distribution was very similar to ours, only found genotype related differences in the bone mineral density in women in the 75-80 year old age group, younger groups showed no difference between the genotypes. 
